FTY720 Nanoformulation Induces O-GlcNacylation of Synuclein to Alleviate Synucleinopathy
ACS Chemical Neuroscience · 2024
DOI: 10.1021/acschemneuro.3c00545 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2024. Verfasst von Mohammed Nadim Sardoiwala und 4 weiteren Autor:innen. Beteiligte Einrichtung: Epigenetics Research Laboratory, Institute of Nano Science and Technology, Knowledge City, Sector 81, Mohali, Punjab 140306, India. Hauptthemen laut MEDLINE: Synucleinopathies, Parkinson Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Indian Council of Medical Research, Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Epigenetics Research Laboratory, Institute of Nano Science and Technology, Knowledge City, Sector 81, Mohali, Punjab 140306, India.
ORCID-Profile: Mohammed Nadim Sardoiwala, Surajit Karmakar, Subhasree Roy Choudhury
Förderung
- Indian Council of Medical Research
- Department of Biotechnology, Ministry of Science and Technology, India
Zitieren
APA
Sardoiwala, M. N., Boddu, M., Biswal, L., Karmakar, S., & Choudhury, S. R. (2024). FTY720 Nanoformulation Induces O-GlcNacylation of Synuclein to Alleviate Synucleinopathy. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.3c00545
Vancouver
Sardoiwala MN, Boddu M, Biswal L, Karmakar S, Choudhury SR. FTY720 Nanoformulation Induces O-GlcNacylation of Synuclein to Alleviate Synucleinopathy. ACS Chemical Neuroscience. 2024. doi:10.1021/acschemneuro.3c00545
BibTeX
@article{Sardoiwala2024,
author = {Sardoiwala, Mohammed Nadim and Boddu, Mrunalini and Biswal, Liku and Karmakar, Surajit and Choudhury, Subhasree Roy},
title = {FTY720 Nanoformulation Induces O-GlcNacylation of Synuclein to Alleviate Synucleinopathy},
journal = {ACS Chemical Neuroscience},
year = {2024},
doi = {10.1021/acschemneuro.3c00545}
}
EUVIMED